T-cell, Thymocytes cells therapy
Q. Recently T-Cell therapy has shown promising results in cancer treatment. What are T-Cells?- Published on 16 Feb 16a. Thymocytes cells
b. T type RBC’s
c. Cells from Thuringiensis bacteria
d. None of the above
ANSWER: Thymocytes cells
- To administer the T-cell therapy, doctors remove immune cells from patients, tagging them with “receptor” molecules that target a specific cancer, as other T-cells target the flu or infections. They then infuse the cells back in the body.
- T-cell therapy is often considered an option of last resort because reprogramming the immune system can come with dangerous side-effects, including cytokine release syndrome (sCRS) — and overload defence cells.
- Lowering the dose of T-cells can reduce the risk of side-effects.
- T-cells are a living drug, and in particular they have the potential to persist in our body for our whole lives. This is a living therapy
